Neurocrine Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	428	341.3	249.7	154.5	89.6	407.3	Upgrade
Depreciation & Amortization	29.7	27.1	21.3	15.6	10.9	8.6	Upgrade
Other Amortization	-	-	-	-	17.3	21.4	Upgrade
Loss (Gain) From Sale of Investments	-7.7	10.9	-46.7	-27.1	-13.5	17.7	Upgrade
Stock-Based Compensation	225.7	195.5	194.3	173.1	134.2	100	Upgrade
Other Operating Activities	128.1	39.8	-56.9	90.7	1.3	-288.6	Upgrade
Change in Accounts Receivable	-246.9	-39.8	-89.3	-162.2	-28.4	-30.5	Upgrade
Change in Inventory	-23.5	-19.1	5.4	-2.6	-2.5	-10.7	Upgrade
Change in Accounts Payable	146.6	29	64.3	114.6	56.8	26.9	Upgrade
Change in Other Net Operating Assets	19.6	10.7	47.8	-17.2	-9.2	-23.6	Upgrade
Operating Cash Flow	636.8	595.4	389.9	339.4	256.5	228.5	Upgrade
Operating Cash Flow Growth	33.67%	52.71%	14.88%	32.32%	12.25%	55.44%	Upgrade
Capital Expenditures	-43.7	-38.2	-28.3	-16.5	-23.4	-10.9	Upgrade
Cash Acquisitions	-	-	-	-42.7	-	-	Upgrade
Investment in Securities	-236.1	-88.6	-438.8	-117.9	-106.8	15	Upgrade
Investing Cash Flow	-279.8	-126.8	-467.1	-177.1	-130.2	4.1	Upgrade
Long-Term Debt Repaid	-	-308.8	-	-279	-0.1	-186.9	Upgrade
Net Debt Issued (Repaid)	-	-308.8	-	-279	-0.1	-186.9	Upgrade
Issuance of Common Stock	102.1	122.1	65.3	44.7	27.5	29.1	Upgrade
Repurchase of Common Stock	-467.7	-300	-	-	-	-	Upgrade
Financing Cash Flow	-365.6	-486.7	65.3	-234.3	27.4	-157.8	Upgrade
Foreign Exchange Rate Adjustments	-0.3	-	0.3	-1.3	-	-	Upgrade
Net Cash Flow	-8.9	-18.1	-11.6	-73.3	153.7	74.8	Upgrade
Free Cash Flow	593.1	557.2	361.6	322.9	233.1	217.6	Upgrade
Free Cash Flow Growth	34.77%	54.09%	11.98%	38.52%	7.12%	64.48%	Upgrade
Free Cash Flow Margin	22.11%	23.66%	19.16%	21.69%	20.57%	20.80%	Upgrade
Free Cash Flow Per Share	5.80	5.37	3.58	3.27	2.38	2.23	Upgrade
Cash Interest Paid	-	1.6	3.8	6.6	8.6	11.6	Upgrade
Cash Income Tax Paid	146.6	217.5	51.5	14.4	5.1	15.3	Upgrade
Levered Free Cash Flow	346.19	457.98	439.25	247.63	265.75	278.59	Upgrade
Unlevered Free Cash Flow	346.19	457.98	439.25	247.63	264.58	277.69	Upgrade
Change in Working Capital	-153.7	-19.2	28.2	-67.4	16.7	-37.9	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.